We are live on ! Find out more
ZSPH

ZS PHARMA INC COMS TK (DE)
ZSPH

Delisted

ZSPH was delisted on the 16th of December, 2015.

78 hedge funds and large institutions have $519M invested in ZS PHARMA INC COMS TK (DE) in 2014 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

143% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 14

77% more capital invested

Capital invested by funds: $293M → $519M (+$226M)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

20% more funds holding

Funds holding: 6578 (+13)

Holders
78
Holders Change
+13
Holders Change %
+20%
% of All Funds
2.08%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
24
Increased
34
Reduced
14
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$123M +$66.7M +1,689,700 +134%
DPA
2
Devon Park Associates
$107M +$102M +2,576,723 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$27.8M +$10.9M +277,371 +71%
JHIU
4
Janus Henderson Investors US
Colorado
$26.9M +$1.17M +29,641 +5%
RCM
5
RA Capital Management
Massachusetts
$23.5M
RG
6
Redmile Group
California
$21.8M +$2M +50,570 +11%
PHS
7
PFM Health Sciences
California
$20.8M -$9M -228,095 -31%
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$20.5M
BFA
9
BlackRock Fund Advisors
California
$17.3M +$10.4M +263,430 +173%
RI
10
RTW Investments
New York
$15.6M +$14.8M +374,821 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$14.9M +$1.13M +28,518 +9%
SCM
12
Scopia Capital Management
New York
$9.47M +$9M +227,902 New
EA
13
Emerald Advisers
Pennsylvania
$7.38M +$1.08M +27,381 +18%
WRF
14
Waddell & Reed Financial
Kansas
$6.88M +$4.08M +103,470 +167%
WSA
15
Wall Street Associates
California
$5.84M -$114K -2,900 -2%
EMFAT
16
Emerald Mutual Fund Advisers Trust
Pennsylvania
$5.69M +$28.4K +720 +0.5%
Asset Management One
17
Asset Management One
Japan
$4.64M +$311K +7,892 +8%
RSCM
18
Rock Springs Capital Management
Maryland
$4.45M +$592K +15,000 +16%
VM
19
VHCP Management
New York
$4.16M
Jennison Associates
20
Jennison Associates
New York
$4.04M -$4.18K -106 -0.1%
EI
21
EAM Investors
California
$3.45M +$1.96M +49,558 +148%
State Street
22
State Street
Massachusetts
$3.3M +$919K +23,272 +41%
JP Morgan Chase
23
JP Morgan Chase
New York
$3.18M +$104K +2,641 +4%
Northern Trust
24
Northern Trust
Illinois
$2.84M +$2.09M +53,014 +348%
BIT
25
BlackRock Institutional Trust
California
$2.75M +$388K +9,822 +17%

ZSPH Hedge Fund Activity: Q4 2014 in Review

78 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in ZS PHARMA INC COMS TK (DE) (ZSPH) for Q4 2014, worth a combined $519M — up 77% from $293M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ZSPH positions and 9 closed out — a net gain of 15 holders — while 34 added to existing stakes and 14 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $66.7M. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $19.9M sold.

  • 78 institutional investors held ZS PHARMA INC COMS TK (DE) (ZSPH) as of Q4 2014, up from 65 in Q3 2014.
  • Funds reported $519M of ZS PHARMA INC COMS TK (DE) stock for Q4 2014, up 77% quarter-over-quarter.
  • 24 funds opened new ZS PHARMA INC COMS TK (DE) positions in Q4 2014 and 9 closed out, a net change of +15 holders.
  • The largest ZS PHARMA INC COMS TK (DE) buyer in Q4 2014 was Fidelity Investments, an estimated $66.7M added.
  • The largest ZS PHARMA INC COMS TK (DE) seller in Q4 2014 was Novo Holdings A/S, an estimated $19.9M sold.

Based on aggregated 13F filings for Q4 2014.